Please assess the completion status of the following clinical trial:

Trial Title: Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diminution of vision due to diabetic macular edema.~* CMT ≥ 250 µ.~* Willing to participate in the study.~Exclusion Criteria:~* Unwilling to participate in the study, 2)~* Ischemic RVO,~* previous laser treatment~* Glaucoma, macular ischemia, cataract, vitreous hemorrhage, and neovascularization of the iris,~* patients with previous anti VEGFs or steroid injections or any eye surgery three months before the inclusion,~* Cardiac co-morbidities result in significant hemodynamic changes, 7)Respiratory diseases need treatment with antibiotics,~* Suffering from other chronic diseases as diabetes,~* Patient with allergy from triamcinolone acetonide.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Study Arms:
- Formulated Posterior Sub Tenon Triamcinolone (Type: ACTIVE_COMPARATOR): None
- Posterior Sub Tenon Triamcinolone alone (Type: ACTIVE_COMPARATOR): None
- suprachoroidal Triamcinolone (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).